This isn't really anything we need to debate, but I'm posting it here because it's something we all should know, whether we vaccinate according to the full schedule, on a select/delayed timetable, or not at all. Please feel free to add other articles, if you find any. I think that this is only the tip of the iceberg.
It's extremely important to know this, because most of us grew up believing that medical research (including vaccine research), as *SCIENCE,* is pure, untouched by corruption, and staffed only with selfless, brave souls who want to save humanity. The industry itself feeds that myth. There are a lot of well-meaning people who have no idea how pervasive the corruption is, and who passionately defend the entire industry.
The truth is very unsettling, to say the least. My thanks to MDC member Turquesa for originally finding and posting this on another thread!
From 2010: http://www.thenation.com/article/big-pharma-bad-science#
"In June, the New England Journal of Medicine, one of the most respected medical journals, made a startling announcement. The editors declared that they were dropping their policy stipulating that authors of review articles of medical studies could not have financial ties to drug companies whose medicines were being analyzed.
The reason? The journal could no longer find enough independent experts. Drug company gifts and "consulting fees" are so pervasive that in any given field, you cannot find an expert who has not been paid off in some way by the industry. So the journal settled for a new standard: Their reviewers can have received no more than $10,000 from companies whose work they judge. Isn't that comforting?"
"Compounding the COls inherent in the business of manufacturing vaccines is the fact that vaccine manufacturers sponsor research. The influence of industry is widespread: It affects individuals as well as institutions and study outcomes as well as research initiatives. In a survey of faculty at top US medical research institutions (Tereskerz et al 2009) found over two-thirds of researchers (338 out of 506) received some support from industry."